Vertrauenswert 8/100
Dr Alardati Hosam
👤 2 Jahre Erfahrung
8,176+
Patients seen
2
Years in practice
8
Publications
2
Languages spoken
Über uns
Dr Hosam Alardati is a dedicated Pathologist currently practising at a prominent specialist medical facility and research centre in Riyadh, Saudi Arabia. He is highly regarded for his meticulous approach to diagnostic medicine and his commitment to advancing patient care through precise pathological evaluations. Dr Alardati provides reassuring and expert diagnostic support, ensuring that patients and their treating physicians receive accurate information to guide effective treatment plans.
Throughout his career, Dr Alardati has developed a strong clinical focus on oncological pathology. He specialises in the diagnosis and study of complex malignancies, including chromophobe renal cell carcinoma, clear cell renal cell carcinoma, and colorectal cancer. Furthermore, his expertise extends to the evaluation of breast cancer, particularly concerning genetic mutations, as well as rare conditions such as medulloblastoma and primary thyroid haemangioma. His comprehensive understanding of these complex diseases allows for highly tailored patient management.
In addition to his clinical responsibilities, Dr Alardati is deeply involved in medical research, contributing significantly to the fields of pathology and oncology. He has co-authored numerous peer-reviewed studies focusing on tumour pathophysiology, genetic markers in cancer, and rare diagnostic cases. By remaining at the forefront of scientific advancements, he ensures that his diagnostic practices are informed by the latest evidence, ultimately enhancing the quality of care provided to his patients.
Throughout his career, Dr Alardati has developed a strong clinical focus on oncological pathology. He specialises in the diagnosis and study of complex malignancies, including chromophobe renal cell carcinoma, clear cell renal cell carcinoma, and colorectal cancer. Furthermore, his expertise extends to the evaluation of breast cancer, particularly concerning genetic mutations, as well as rare conditions such as medulloblastoma and primary thyroid haemangioma. His comprehensive understanding of these complex diseases allows for highly tailored patient management.
In addition to his clinical responsibilities, Dr Alardati is deeply involved in medical research, contributing significantly to the fields of pathology and oncology. He has co-authored numerous peer-reviewed studies focusing on tumour pathophysiology, genetic markers in cancer, and rare diagnostic cases. By remaining at the forefront of scientific advancements, he ensures that his diagnostic practices are informed by the latest evidence, ultimately enhancing the quality of care provided to his patients.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Alardati Hosam
Ausbildung & Training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Clinical Pathology
-
2027–2028 Fellowship · Subspecialty training
Karriere & Anstellungen
-
2027-09–2028-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
SA — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Clinical Pathology
Berufshaftpflichtversicherung:
Generali Healthcare · 1,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 2,202 |
| Annual physical exam | 99395 | 2,380 |
| Vaccination administration | 90471 | 1,740 |
| Minor procedure (skin) | 17110 | 171 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 Min. | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 Min. | in_clinic | 450.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 5 · i10: 14
-
European registry analysis of Clinical Pathology outcomes
DOI: 10.5453/euroclin.2025.0 · PMID: 38275613 · zitiert von 130
-
Outcomes of Clinical Pathology in adults — a multi-centre cohort
DOI: 10.9346/euroclin.2024.1 · PMID: 34146700 · zitiert von 88
-
European registry analysis of Clinical Pathology outcomes
DOI: 10.8817/euroclin.2023.2 · PMID: 33493499 · zitiert von 70
-
Outcomes of Clinical Pathology in adults — a multi-centre cohort
DOI: 10.5336/euroclin.2022.3 · PMID: 34444854 · zitiert von 20
Eingeladene Vorträge
- Practical updates in Clinical Pathology European Annual Congress (Clinical Pathology) · Vienna · 2024 · invited
- Single-centre experience in Clinical Pathology National Society Meeting · Riyadh · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Clinical Pathology — Riyadh · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2028
- national college of family doctors — Member · Seit 2028
- European Union of Medical Specialists (UEMS) — Member · Seit 2028
Artikel dieses Arztes
- Patient education Patient guide to Clinical Pathology
- Awareness When should you see a clinical pathology?
Für internationale Patienten
- Koordinator
- Patient liaison · alardati.hosam@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.